Cardiol Therapeutics's market cap is currently $152.60M. The company's EPS TTM is C$-0.531; its P/E ratio is ―; Cardiol Therapeutics is scheduled to report earnings on March 27, 2025, and the estimated EPS forecast is C$-0.13. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	C$ 0.00	C$ 0.00	C$ 78.76K	C$ 0.00	C$ 0.00
Gross Profit	C$ -248.35K	C$ -219.91K	C$ 78.76K	C$ -229.54K	C$ -150.57K
Operating Income	C$ -29.79M	C$ -50.34M	C$ -45.47M	C$ -20.61M	C$ -13.58M
EBITDA	C$ -27.88M	C$ -30.71M	C$ -38.44M	C$ -20.41M	C$ -13.53M
Net Income	C$ -28.13M	C$ -11.52M	C$ -24.72M	C$ -20.65M	C$ -13.98M
Balance Sheet
Cash & Short-Term Investments	C$ 34.93M	C$ 59.47M	C$ 83.90M	C$ 14.03M	C$ 6.96M
Total Assets	C$ 36.70M	C$ 62.03M	C$ 87.88M	C$ 15.89M	C$ 15.50M
Total Debt	C$ 158.53K	C$ 72.87K	C$ 117.58K	C$ 156.57K	C$ 190.75K
Net Debt	C$ -34.77M	C$ -59.40M	C$ -83.78M	C$ -13.87M	C$ -6.77M
Total Liabilities	C$ 8.45M	C$ 9.83M	C$ 11.64M	C$ 2.62M	C$ 830.83K
Stockholders' Equity	C$ 28.25M	C$ 52.20M	C$ 76.24M	C$ 13.27M	C$ 14.67M
Cash Flow
Free Cash Flow	-	C$ -27.30M	C$ -23.56M	C$ -9.23M	C$ -11.80M
Operating Cash Flow	-	C$ -27.22M	C$ -23.55M	C$ -9.19M	C$ -11.38M
Investing Cash Flow	C$ -64.31K	C$ -74.71K	C$ -12.92K	C$ -40.60K	C$ -424.31K
Financing Cash Flow	-	C$ -53.93K	C$ 93.44M	C$ 16.30M	C$ 2.03M

Currency in CAD

Cardiol Therapeutics Earnings and Revenue History

Income Statement >

Cardiol Therapeutics Debt to Assets

Balance Sheet >

Cardiol Therapeutics Cash Flow

Cash Flow >

Cardiol Therapeutics Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing